Home » Topics » BioWorld

BioWorld
RSS

ECOGEN GETS EQUITY INVESTMENT

Nov. 5, 1991

APPLIED BIOSCIENCE ACQUIRES PHARMACO

Nov. 5, 1991

FDA APPROVES TRIALS OF PSORIASIS DRUG

Nov. 5, 1991

IMMUNOGEN RETURNS TO OFFERINGS WELL

Nov. 5, 1991

GENZYME GETS DIAGNOSTIC ENZYME BUSINESS

Nov. 5, 1991

PET CANCER TREATMENT CONDITIONALLY APPROVED

Nov. 5, 1991

IMMUNE TO FILE IND FOR ARTHRITIS VACCINE

Nov. 5, 1991

GENTA FILES 'QUIET' IPO

Nov. 5, 1991

BIOTECH BUBBLE MAY BE READY TO BURST

Nov. 5, 1991

SPHINX INKS FOUR-YEAR DEAL WITH LILLY

Nov. 5, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...